Trodelvy has been Approved for ER+/HER2- Patients with Advanced or Metastatic Breast Cancers
XTalks
FEBRUARY 7, 2023
Current treatments for HR+ breast cancer patients include hormonal therapies, chemotherapies for those that do not respond to hormonal therapy alone and targeted therapies, either stand-alone or in combination with hormonal therapies. What does this Approval Mean for Breast Cancer Patients?
Let's personalize your content